Ticker Details
Reviva Pharmaceuticals Holdings, Inc.
IPO Date:	October 15, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$10.82M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 4.77%
Avg Daily Range (30 D):	$0.11 | 7.90%
Avg Daily Range (90 D):	$0.05 | 5.71%

Institutional Daily Volume
Avg Daily Volume:	1.21M
Avg Daily Volume (30 D):	1.69M
Avg Daily Volume (90 D):	3.59M

Trade Size
Avg Trade Size (Sh.):	354
Avg Trade Size (Sh.) (30 D):	382
Avg Trade Size (Sh.) (90 D):	617

Institutional Trades
Total Institutional Trades:	16
Avg Institutional Trade:	$.8M
Avg Institutional Trade (30 D):	$1.08M
Avg Institutional Trade (90 D):	$1.08M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.9M
Avg Closing Trade (30 D):	$1.08M
Avg Closing Trade (90 D):	$1.08M
Avg Closing Volume:	34.85K

News

Mar 23, 2026 @ 12:00 PM Reviva Pharmaceuticals Holdings, Inc. Announces Cl... Source: Globe Newswire

Mar 19, 2026 @ 2:34 AM Reviva Pharmaceuticals Holdings, Inc. Announces Pr... Source: Globe Newswire

Mar 19, 2026 @ 2:34 AM Reviva Pharmaceuticals Holdings, Inc. Announces Pr... Source: Na

Dec 29, 2025 @ 1:00 PM Reviva to Present at the Sachs 9th Annual Neurosci... Source: Not Specified

Oct 28, 2025 @ 12:00 PM Reviva to Present Negative Symptom Data for Brilar... Source: Reviva Pharmaceuticals Holdings, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-5.48	$-5.19	$-5.48
Diluted EPS
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-19.86M	$-3.37M	$-19.86M
Operating Income / Loss	$-20.2M	$-3.56M	$-20.2M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Mar 09, 2026	1:20